MedTrace Logo

Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department

NCT03571737 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-03-25

Study results available
· View outcomes & findings →

Summary

This study evaluates the addition of a lidocaine patch to ibuprofen in the treatment of acute musculoskeletal pains. Half of the participants will get only ibuprofen for their pain, while other half will receive lidocaine patch plus the ibuprofen. After addition of the pain medications, the participants will be followed for their pain scores and return visits.

Conditions

  • Acute Musculoskeletal Disease
  • Sprains
  • Sprains and Strains
  • Injuries
  • Emergencies
  • Trauma
  • Acute Pain

Interventions

DRUG

Ibuprofen

Ibuprofen tablet

DRUG

Lidocaine Patch 4%

Lidocaine patch

Sponsors & Collaborators

  • East Carolina University

    lead OTHER

Principal Investigators

  • Jennifer Stahl, MD · East Carolina University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-23
Primary Completion
2020-12-30
Completion
2021-01-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571737 on ClinicalTrials.gov